deltatrials
Terminated PHASE1/PHASE2 INTERVENTIONAL 6-arm NCT00801931

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Double Umbilical Cord Blood Transplantation for Patients With Malignant and Non-Malignant Disorders

Sponsor: Columbia University

Conditions Anemia Immunodeficiencies Leukemia Lymphoma Neuroblastoma
Interventions Alemtuzumab Busulfan Cyclophosphamide Fludarabine Horse Antithymocyte Globulin Melphalan Phenytoin Rabbit Antithymocyte Globulin Thiotepa Total Body Irradiation
Updated 9 times since 2017 Last updated: Mar 4, 2019 Started: Sep 6, 2007 Primary completion: May 5, 2009 Completion: May 5, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Poor accrual

Other terminated trials from Columbia University

See all terminations from Columbia University

Other Anemia trials with similar outcome

Browse all Anemia trials

A PHASE1/PHASE2 clinical study on Anemia and Immunodeficiencies, this trial is terminated or withdrawn. The trial is conducted by Columbia University and has accumulated 9 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshotTerminated~Apr 2019 – ~Jan 2021 · 21 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE1_PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE1_PHASE2

  5. Dec 2021 — Dec 2022 [monthly]

    Terminated PHASE1_PHASE2

▶ Show 4 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE1_PHASE2

  2. Apr 2019 — Jan 2021 [monthly]

    Terminated PHASE1_PHASE2

  3. Jun 2018 — Apr 2019 [monthly]

    Terminated PHASE1_PHASE2

  4. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE1_PHASE2

    First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Columbia University
Data source: Columbia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations